A246710 Stock Overview
Develops and commercializes various regenerative medical technologies. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 3/6 |
| Dividends | 0/6 |
My Notes
Capture your thoughts, links and company narrative
T&R Biofab Co., Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₩4,090.00 |
| 52 Week High | ₩11,100.00 |
| 52 Week Low | ₩3,420.00 |
| Beta | 0.78 |
| 1 Month Change | -30.91% |
| 3 Month Change | -38.59% |
| 1 Year Change | -54.20% |
| 3 Year Change | -83.71% |
| 5 Year Change | -19.01% |
| Change since IPO | -34.56% |
Recent News & Updates
Recent updates
Is T&R Biofab (KOSDAQ:246710) Using Debt Sensibly?
Feb 26
Do Insiders Own Lots Of Shares In T&R Biofab Co., Ltd. (KOSDAQ:246710)?
Mar 09Can You Imagine How T&R Biofab's (KOSDAQ:246710) Shareholders Feel About The 65% Share Price Increase?
Jan 12
Do Institutions Own T&R Biofab Co., Ltd. (KOSDAQ:246710) Shares?
Nov 18Shareholder Returns
| A246710 | KR Medical Equipment | KR Market | |
|---|---|---|---|
| 7D | -16.7% | -3.7% | -1.9% |
| 1Y | -54.2% | -4.3% | -9.5% |
Return vs Industry: A246710 underperformed the KR Medical Equipment industry which returned -4.3% over the past year.
Return vs Market: A246710 underperformed the KR Market which returned -9.5% over the past year.
Price Volatility
| A246710 volatility | |
|---|---|
| A246710 Average Weekly Movement | 9.1% |
| Medical Equipment Industry Average Movement | 7.6% |
| Market Average Movement | 6.6% |
| 10% most volatile stocks in KR Market | 12.8% |
| 10% least volatile stocks in KR Market | 3.3% |
Stable Share Price: A246710 has not had significant price volatility in the past 3 months compared to the KR market.
Volatility Over Time: A246710's weekly volatility (9%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2013 | n/a | Wonsoo Yun | www.tnrbiofab.com |
T&R Biofab Co., Ltd. develops and commercializes various regenerative medical technologies. It offers 3D-printed medical devices; and bio-surgical solutions, which includes wound dressing and acellular dermal matrix, as well as biomaterials and biopharmaceuticals. The company was founded in 2013 and is based in Siheung-si, South Korea.
T&R Biofab Co., Ltd. Fundamentals Summary
| A246710 fundamental statistics | |
|---|---|
| Market cap | ₩88.13b |
| Earnings (TTM) | -₩13.74b |
| Revenue (TTM) | ₩5.08b |
17.3x
P/S Ratio-6.4x
P/E RatioIs A246710 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| A246710 income statement (TTM) | |
|---|---|
| Revenue | ₩5.08b |
| Cost of Revenue | ₩3.66b |
| Gross Profit | ₩1.42b |
| Other Expenses | ₩15.16b |
| Earnings | -₩13.74b |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -637.68 |
| Gross Margin | 27.95% |
| Net Profit Margin | -270.43% |
| Debt/Equity Ratio | 180.0% |
How did A246710 perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/26 02:54 |
| End of Day Share Price | 2024/12/26 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
T&R Biofab Co., Ltd. is covered by 1 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Pyeongkuk Park | NH Investment & Securities Co., Ltd. |